Radiation-induced bystander signalling in cancer therapy

по Prise, Kevin M., O'Sullivan, Joe M.
Опубликовано 2009

Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy

по Nugent, Brenda, Lewis, Sian, O'Sullivan, Joe M
Опубликовано в: Cochrane Database Syst Rev (2013)

What is the Role of the Bystander Response in Radionuclide Therapies?

по Brady, Darren, O’Sullivan, Joe M., Prise, Kevin M.
Опубликовано 2013

Opportunities for research in molecular radiotherapy

по Flux, Glenn D, O'Sullivan, Joe, Gaze, Mark N, Prise, Kevin M
Опубликовано в: Br J Radiol (2017)

An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol

по Ruane-McAteer, Eimear, O’Sullivan, Joe, Porter, Sam, Venderbos, Lionne, Prue, Gillian
Опубликовано в: BMC Cancer (2016)

Fiducial marker guided prostate radiotherapy: a review

по O'Neill, Angela G M, Jain, Suneil, Hounsell, Alan R, O'Sullivan, Joe M
Опубликовано в: Br J Radiol (2016)

A study of the biological effects of modulated 6 MV radiation fields

по Butterworth, Karl T, McGarry, Conor K, O’Sullivan, Joe M, Hounsell, Alan R, Prise, Kevin M
Опубликовано 2010

A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy

по Haseen, Farhana, Murray, Liam J, O'Neill, Roisin F, O'Sullivan, Joe M, Cantwell, Marie M
Опубликовано 2010

OUT-OF-FIELD CELL SURVIVAL FOLLOWING EXPOSURE TO INTENSITY-MODULATED RADIATION FIELDS

по Butterworth, Karl T., McGarry, Conor K., Trainor, Colman, O'Sullivan, Joe M., Hounsell, Alan R., Prise, Kevin M.
Опубликовано 2011

Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT)

по Brown, Malcolm, Murphy, Marie, McDermott, Lauri, McAneney, Helen, O’Sullivan, Joe M., Jain, Suneil, Prue, Gillian
Опубликовано в: Pilot Feasibility Stud (2019)

The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies.

по Cardwell, Chris R., O’Sullivan, Joe M., Jain, Suneil, Harbinson, Mark T., Cook, Michael B., Hicks, Blánaid M., Menamin, Úna C. Mc
Опубликовано в: Epidemiology (2020)

DNA Damage Responses following Exposure to Modulated Radiation Fields

по Trainor, Colman, Butterworth, Karl T., McGarry, Conor K., McMahon, Stephen J., O’Sullivan, Joe M., Hounsell, Alan R., Prise, Kevin M.
Опубликовано 2012

The mediastinal staging accuracy of 18F-Fluorodeoxyglycose Positron Emission Tomography / Computed Tomography in non-small cell lung cancer with variable time intervals to surgery.

по Booth, Karen, Hanna, Gerard G, McGonigle, Niall, McManus, Kieran G, McGuigan, James, O’Sullivan, Joe, Lynch, Tom, McAleese, Jonathan
Опубликовано 2013

A Kinetic-Based Model of Radiation-Induced Intercellular Signalling

по McMahon, Stephen J., Butterworth, Karl T., Trainor, Colman, McGarry, Conor K., O’Sullivan, Joe M., Schettino, Giuseppe, Hounsell, Alan R., Prise, Kevin M.
Опубликовано 2013

ELEVATION OF C-FLIP IN CASTRATE-RESISTANT PROSTATE CANCER ANTAGONIZES THERAPEUTIC RESPONSE TO ANDROGEN-RECEPTOR TARGETED THERAPY

по McCourt, Clare, Maxwell, Pamela, Mazzucchelli, Roberta, Montironi, Rodolfo, Scarpelli, Marina, Salto-Tellez, Manuel, O’Sullivan, Joe M., Longley, Daniel B., Waugh, David J.J.
Опубликовано 2012

Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy

по Denis-Bacelar, Ana M, Chittenden, Sarah J, McCready, V Ralph, Divoli, Antigoni, Dearnaley, David P, O’Sullivan, Joe M, Johnson, Bernadette, Flux, Glenn D
Опубликовано в: Br J Radiol (2018)

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy

по Lyons, Ciara A., King, Raymond B., Osman, Sarah O.S., McMahon, Stephen J., O’Sullivan, Joe M., Hounsell, Alan R., Jain, Suneil, McGarry, Conor K.
Опубликовано в: Radiat Oncol (2017)

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

по Heidenreich, Axel, Gillessen, Silke, Heinrich, Daniel, Keizman, Daniel, O’Sullivan, Joe M., Carles, Joan, Wirth, Manfred, Miller, Kurt, Reeves, John, Seger, Monica, Nilsson, Sten, Saad, Fred
Опубликовано в: BMC Cancer (2019)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis

по McCourt, Clare M., McArt, Darragh G., Mills, Ken, Catherwood, Mark A., Maxwell, Perry, Waugh, David J., Hamilton, Peter, O'Sullivan, Joe M., Salto-Tellez, Manuel
Опубликовано 2013

Phase I/II trials of (186)Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival

по Denis-Bacelar, Ana M., Chittenden, Sarah J., Dearnaley, David P., Divoli, Antigoni, O’Sullivan, Joe M., McCready, V. Ralph, Johnson, Bernadette, Du, Yong, Flux, Glenn D.
Опубликовано в: Eur J Nucl Med Mol Imaging (2016)